Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 5614747, 10 pages
http://dx.doi.org/10.1155/2016/5614747
Research Article

Effects of Jia-Wei-Xiao-Yao-San on the Peripheral and Lymphatic Pharmacokinetics of Paclitaxel in Rats

1Institute of Traditional Medicine, National Yang-Ming University, No. 155, Section 2, Li-Nong Street, Taipei 112, Taiwan
2Graduate Institute of Acupuncture Science, China Medical University, No. 91, Hsueh-Shih Road, Taichung 404, Taiwan
3School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, No. 100, Shih-Chuan 1st Road, Kaohsiung 807, Taiwan
4Department of Education and Research, Taipei City Hospital, No. 145, Zhengzhou Road, Datong District, Taipei 103, Taiwan

Received 15 January 2016; Accepted 16 February 2016

Academic Editor: José L. Ríos

Copyright © 2016 Mei-Ling Hou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Schmidt, “Chemotherapy in early breast cancer: when, how and which one?” Breast Care, vol. 9, no. 3, pp. 154–160, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Ma and R. J. Mumper, “Paclitaxel nano-delivery systems: a comprehensive review,” Journal of Nanomedicine and Nanotechnology, vol. 4, no. 2, Article ID 1000164, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Iwamoto, “Clinical application of drug delivery systems in cancer chemotherapy: review of the efficacy and side effects of approved drugs,” Biological and Pharmaceutical Bulletin, vol. 36, no. 5, pp. 715–718, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Mandilaras, N. Bouganim, J. Spayne et al., “Concurrent chemoradiotherapy for locally advanced breast cancer—time for a new paradigm?” Current Oncology, vol. 22, no. 1, pp. 25–32, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Y. K. Fong, Q. Gao, and Z. Zuo, “Interaction of carbamazepine with herbs, dietary supplements, and food: a systematic review,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 898261, 15 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Makino, T. Inagaki, K.-I. Komatsu, and Y. Kano, “Pharmacokinetic interactions between Japanese traditional kampo medicine and modern medicine (IV). Effect of Kamisyoyosan and Tokisyakuyakusan on the pharmacokinetics of etizolam in rats,” Biological and Pharmaceutical Bulletin, vol. 28, no. 2, pp. 280–284, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Ohnishi and H. Takeda, “Herbal medicines for the treatment of cancer chemotherapy-induced side effects,” Frontiers in Pharmacology, vol. 6, article 14, 2015. View at Publisher · View at Google Scholar
  8. J.-N. Lai, C.-T. Wu, and J.-D. Wang, “Prescription pattern of Chinese herbal products for breast cancer in Taiwan: a population-based study,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 891893, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. B.-R. Wang, Y.-L. Chang, T.-J. Chen et al., “Coprescription of Chinese herbal medicine and Western medication among female patients with breast cancer in Taiwan: analysis of national insurance claims,” Patient Preference and Adherence, vol. 8, pp. 671–682, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Rochat, “Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism,” Clinical Pharmacokinetics, vol. 44, no. 4, pp. 349–366, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Jin, H. Bi, J. Hu et al., “Effect of Wuzhi tablet (Schisandra sphenanthera extract) on the pharmacokinetics of paclitaxel in rats,” Phytotherapy Research, vol. 25, no. 8, pp. 1250–1253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. H. Park, J. H. Park, H. J. Hur, J. S. Woo, and H. J. Lee, “Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats,” European Journal of Pharmaceutical Sciences, vol. 45, no. 3, pp. 296–301, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Václavíková, S. Horský, P. Šimek, and I. Gut, “Paclitaxel metabolism in rat and human liver microsomes is inhibited by phenolic antioxidants,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 368, no. 3, pp. 200–209, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. J. H. Lee, A. Lee, J.-H. Oh, and Y.-J. Lee, “Comparative pharmacokinetic study of paclitaxel and docetaxel in streptozotocin-induced diabetic rats,” Biopharmaceutics and Drug Disposition, vol. 33, no. 8, pp. 474–486, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. A. R. Tan, A. Dowlati, M. N. Stein et al., “Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies,” British Journal of Cancer, vol. 110, no. 11, pp. 2647–2654, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Wang, L. Song, N. Li et al., “Pharmacokinetics and biodistribution study of paclitaxel liposome in Sprague-Dawley rats and Beagle dogs by liquid chromatography-tandem mass spectrometry,” Drug Research, vol. 63, no. 11, pp. 603–606, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. C.-M. Lu, M.-L. Hou, L.-C. Lin, and T.-H. Tsai, “Chemical and physical methods to analyze a multicomponent traditional chinese herbal prescription using LC-MS/MS, electron microscope, and congo red staining,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 952796, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Reagan-Shaw, M. Nihal, and N. Ahmad, “Dose translation from animal to human studies revisited,” FASEB Journal, vol. 22, no. 3, pp. 659–661, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Boyd, V. Risovic, P. Jull, E. Choo, and K. M. Wasan, “A stepwise surgical procedure to investigate the lymphatic transport of lipid-based oral drug formulations: cannulation of the mesenteric and thoracic lymph ducts within the rat,” Journal of Pharmacological and Toxicological Methods, vol. 49, no. 2, pp. 115–120, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Ionac, “One technique, two approaches, and results: thoracic duct cannulation in small laboratory animals,” Microsurgery, vol. 23, no. 3, pp. 239–245, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. C. H. Hsieh, M. L. Hou, L. Y. Wang, H. Tai, T. Tsai, and Y. Chen, “Local pelvic irradiation modulates pharmacokinetics of 5-fluorouracil in the plasma but not in the lymphatic system,” BMC Cancer, vol. 15, no. 1, article 316, 2015. View at Publisher · View at Google Scholar
  22. T.-H. Tsai, Y.-J. Chen, M.-L. Hou, L.-Y. Wang, H.-C. Tai, and C.-H. Hsieh, “Pelvic irradiation modulates the pharmacokinetics of cisplatin in the plasma and lymphatic system,” American Journal of Translational Research, vol. 7, no. 2, pp. 375–384, 2015. View at Google Scholar
  23. D. Zimmer, “New US FDA draft guidance on bioanalytical method validation versus current FDA and EMA guidelines: chromatographic methods and ISR,” Bioanalysis, vol. 6, no. 1, pp. 13–19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Jain, A. Gulbake, A. Jain et al., “Development and validation of the HPLC method for simultaneous estimation of paclitaxel and topotecan,” Journal of Chromatographic Science, vol. 52, no. 7, pp. 697–703, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. S. S. Vasudev, F. J. Ahmad, R. K. Khar et al., “Validated HPLC method for the simultaneous determination of taxol and ellagic acid in a Punica granatum fruit extract containing combination formulation,” Pharmazie, vol. 67, no. 10, pp. 834–838, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Carlier, J. Guitton, L. Romeuf et al., “Screening approach by ultra-high performance liquid chromatography-tandem mass spectrometry for the blood quantification of thirty-four toxic principles of plant origin. Application to forensic toxicology,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 975, pp. 65–76, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Liu, X. Gou, X. Bai et al., “Simultaneous determination of seven taxoids in rat plasma by UPLC-MS/MS and pharmacokinetic study after oral administration of Taxus yunnanensis extracts,” Journal of Pharmaceutical and Biomedical Analysis, vol. 107, pp. 346–354, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. J. A. Siddiqui, A. Singh, M. Chagtoo, N. Singh, M. Godbole, and B. Chakravarti, “Phytochemicals for breast cancer therapy: current status and future implications,” Current Cancer Drug Targets, vol. 15, no. 2, pp. 116–135, 2015. View at Publisher · View at Google Scholar
  29. F. Qi, A. Li, Y. Inagaki et al., “Chinese herbal medicines as adjuvant treatment during chemoor radio-therapy for cancer,” BioScience Trends, vol. 4, no. 6, pp. 297–307, 2010. View at Google Scholar · View at Scopus
  30. K. K. Kumar, L. Priyanka, K. Gnananath, P. R. Babu, and S. Sujatha, “Pharmacokinetic drug interactions between apigenin, rutin and paclitaxel mediated by P-glycoprotein in rats,” European Journal of Drug Metabolism and Pharmacokinetics, vol. 40, no. 3, pp. 267–276, 2015. View at Publisher · View at Google Scholar
  31. Q. Cai, X. Deng, Z. Li, D. An, T. Shen, and M. Zhong, “Effects of lipid vehicle and P-glycoprotein inhibition on the mesenteric lymphatic transport of paclitaxel in unconscious, lymph duct-cannulated rats,” Drug Delivery, vol. 23, no. 1, pp. 147–153, 2014. View at Publisher · View at Google Scholar
  32. L.-Y. Wang, Y.-P. Tang, X. Liu et al., “Effects of ferulic acid on antioxidant activity in Angelicae Sinensis Radix, Chuanxiong Rhizoma, and their combination,” Chinese Journal of Natural Medicines, vol. 13, no. 6, pp. 401–408, 2015. View at Publisher · View at Google Scholar
  33. G.-S. Shan, L.-X. Zhang, Q.-M. Zhao et al., “Metabolomic study of raw and processed Atractylodes macrocephala Koidz by LC-MS,” Journal of Pharmaceutical and Biomedical Analysis, vol. 98, pp. 74–84, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Ji, T. Wang, Z.-F. Wei et al., “Paeoniflorin, the main active constituent of Paeonia lactiflora roots, attenuates bleomycin-induced pulmonary fibrosis in mice by suppressing the synthesis of type I collagen,” Journal of Ethnopharmacology, vol. 149, no. 3, pp. 825–832, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Y.-K. Law, J.-F. Mo, and V. K.-W. Wong, “Autophagic effects of Chaihu (dried roots of Bupleurum Chinense DC or Bupleurum scorzoneraefolium WILD),” Chinese Medicine, vol. 9, no. 1, article 21, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. J.-L. Ríos, “Chemical constituents and pharmacological properties of Poria cocos,” Planta Medica, vol. 77, no. 7, pp. 681–691, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. X. Wang, H. Zhang, L. Chen, L. Shan, G. Fan, and X. Gao, “Liquorice, a unique ‘guide drug’ of traditional Chinese medicine: a review of its role in drug interactions,” Journal of Ethnopharmacology, vol. 150, no. 3, pp. 781–790, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. C. H. Lau, C. M. Chan, Y. W. Chan et al., “Pharmacological investigations of the anti-diabetic effect of Cortex Moutan and its active component paeonol,” Phytomedicine, vol. 14, no. 11, pp. 778–784, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Cheng, L.-C. Lin, C.-H. Lin, and T.-H. Tsai, “Comparative oral bioavailability of geniposide following oral administration of geniposide, Gardenia jasminoides Ellis fruits extracts and Gardenia herbal formulation in rats,” Journal of Pharmacy and Pharmacology, vol. 66, no. 5, pp. 705–712, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Ahmad, M. U. Rehman, I. Amin et al., “A review on pharmacological properties of zingerone (4-(4-Hydroxy-3-methoxyphenyl)-2-butanone),” The Scientific World Journal, vol. 2015, Article ID 816364, 6 pages, 2015. View at Publisher · View at Google Scholar
  41. W. J. Zhang, K. Yang, C. X. You et al., “Contact toxicity and repellency of the essential oil from Mentha haplocalyx Briq. against Lasioderma serricorne,” Chemistry & Biodiversity, vol. 12, no. 5, pp. 832–839, 2015. View at Publisher · View at Google Scholar
  42. C.-X. Liu, X.-L. Yi, D.-Y. Si, X.-F. Xiao, X. He, and Y.-Z. Li, “Herb-drug interactions involving drug metabolizing enzymes and transporters,” Current Drug Metabolism, vol. 12, no. 9, pp. 835–849, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. A. A. Gashev, “Physiologic aspects of lymphatic contractile function: current perspectives,” Annals of the New York Academy of Sciences, vol. 979, pp. 178–187, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Binder, “Evolution of Taxanes in the treatment of metastatic breast cancer,” Clinical Journal of Oncology Nursing, vol. 17, no. 1, pp. 9–14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. A. C. Boileau, N. R. Merchen, K. Wasson, C. A. Atkinson, and J. W. Erdman Jr., “Cis-lycopene is more bioavailable than trans-lycopene in vitro and in vivo in lymph-cannulated ferrets,” Journal of Nutrition, vol. 129, no. 6, pp. 1176–1181, 1999. View at Google Scholar · View at Scopus
  46. I.-L. Chen, Y.-J. Tsai, C.-M. Huang, and T.-H. U. Tsai, “Lymphatic absorption of quercetin and rutin in rat and their pharmacokinetics in systemic plasma,” Journal of Agricultural and Food Chemistry, vol. 58, no. 1, pp. 546–551, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. W. Faisal, C. M. O'Driscoll, and B. T. Griffin, “Bioavailability of lycopene in the rat: the role of intestinal lymphatic transport,” Journal of Pharmacy and Pharmacology, vol. 62, no. 3, pp. 323–331, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Manita, T. Sudo, and H. Asano, “Demonstration of parotin in thoracic duct lymph and portal vein blood upon intestinal administration in the rat,” Endocrinologia Japonica, vol. 20, no. 5, pp. 463–474, 1973. View at Publisher · View at Google Scholar · View at Scopus
  49. Y.-J. Tsai and T.-H. Tsai, “Mesenteric lymphatic absorption and the pharmacokinetics of naringin and naringenin in the rat,” Journal of Agricultural and Food Chemistry, vol. 60, no. 51, pp. 12435–12442, 2012. View at Publisher · View at Google Scholar · View at Scopus